Point72 Asia (Singapore)’s Enliven Therapeutics ELVN Stock Holding History

Point72 Asia (Singapore)’s Portfolio ELVN Stock Details ELVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$56.8K	Sell
2025 Q2	$132K	Buy
2025 Q1	$45.2K	Buy